麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Oct 6 2025

Full Issue

Costco Will Offer Wegovy, Ozempic For $499 Monthly To Uninsured Members

Novo Nordisk announced Friday that it wanted to ensure everyone had access to the "authentic" drugs. Also, Sen. Ruben Gallego (D-Ariz.) has pushed for more details regarding the White House's deal with Pfizer; Colorado has placed a price cap on Enbrel, a drug used to treat some autoimmune diseases; and more.

Pharmaceutical company Novo Nordisk announced Friday that Costco will begin selling monthly supplies of Ozempic and Wegovy for $499 to uninsured members. The discounted price comes as more Americans have become aware of GLP-1 weight loss drugs, which have become increasingly popular as people have touted body transformations and health benefits. (Venkat, 10/3)

More on the high cost of pharmaceuticals 鈥

Sen. Ruben Gallego (D-Ariz.) is raising concerns over the lack of details given about President Trump鈥檚 鈥渕ost favored nation鈥 (MFN) pricing deal he announced with Pfizer this week, calling on the company鈥檚 CEO to explain how it plans to execute the agreement. In a letter to Pfizer CEO Albert Bourla, provided to The Hill, Gallego asked for clarity in his agreement with the Trump administration. (Choi, 10/3)

Colorado regulators have approved a dramatic price cap on one of the nation鈥檚 best-selling drugs, cutting its price to less than one-third of its previous level, in a novel attempt by a state to respond to widespread anger over the rising cost of prescriptions. Maryland, Minnesota and Washington also have passed legislation in recent years that enables state officials to set price caps on specific drugs deemed unaffordable, and they are now expected to follow Colorado鈥檚 path. (Whoriskey, 10/4)

After years of work, European officials are nearing the finish line on the biggest shakeup to European pharmaceutical policy in decades, with major impacts on everything from how quickly new medicines are rolled out across the continent to how willing drugmakers are to invest in the E.U. (Joseph, 10/6)

When the Danish drugmaker Novo Nordisk wanted to test whether the main ingredient in Ozempic, its wildly popular weight-loss and diabetes drug, could also treat liver disease, it first needed approval from an ethics panel to ensure the safety of trial volunteers in the United States. ... Yet Novo didn鈥檛 have to venture far to hire an ethics panel for its liver-disease trial in May 2024: It chose WCG Clinical, a review board partly owned by its own corporate parent, The New York Times found. (Bogdanich, Kessler and Singer-Vine, 10/4)

In related news on costs and coverage 鈥

To prevent pneumonia, Carrie Lazoen says her 2-year-old daughter, Emmalyn, needs a 鈥渟haky vest.鈥 Emmy, as her family calls her, has a rare genetic condition called Aicardi syndrome. The disease 鈥 which can shorten life expectancy 鈥 affects her brain, causing seizures, vision problems and significant developmental delays. As a result, Emmy can鈥檛 walk independently. Everyday activities require careful monitoring. She can鈥檛 sit on her own or hold her head up for long. (Edwards, Vespa and Herzberg, 10/4)

Most times, the price you see is the price you pay. But sometimes, all it takes is a phone call to get a better deal. While some people have honed the art of negotiation, eager to bargain down the cost of a new car or streaming service, others are mortified at the very thought. But many consumers simply don鈥檛 realize that rent, medical visits and other bills are not as fixed as they might appear. (Zauzmer Weil, 10/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优